Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › USE OF HYDROXYMATAIRESINOL FOR PREVENTION OF CANCERS, NON-CANCER, HORMONE DEPENDENT DISEASES AND CARDIOVASCULAR DISEASES BY HYDROXYMATAIRESINOL, AND A PHARMACEUTICAL PREPARATION, FOOD ADDITIVE AND FOOD PRODUCT COMPRISING HYDROXYMATAIRESINOL

USE OF HYDROXYMATAIRESINOL FOR PREVENTION OF CANCERS, NON-CANCER, HORMONE DEPENDENT DISEASES AND CARDIOVASCULAR DISEASES BY HYDROXYMATAIRESINOL, AND A PHARMACEUTICAL PREPARATION, FOOD ADDITIVE AND FOOD PRODUCT COMPRISING HYDROXYMATAIRESINOL

US Patent 6451849 · Granted Sep 17, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medicine for Covid-19 and treatment2023
Medicine for Covid-19 and treatment2022
Medicine for Covid-19 and treatment2021
Method for the treatment or prevention of lower urinary tract symptoms2020
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Method for the treatment or prevention of lower urinary tract symptoms2018
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-h2017
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as2017
Method for the alleviation of dyspareunia in women2017
Method for the treatment or prevention of lower urinary tract symptoms2015
Method for the treatment or prevention of lower urinary tract symptoms2015
Estimation and biological consequences of oxidative metabolism2011